Carbon monoxide liberated from co-releasing molecule (CORM-2) attenuates ischemia/reperfusion (I/R)-induced inflammation in the small intestine

Inflammation

Volumn 33, Issue 2, 2010, Pages 92-100

  Katada, Kazuhiro ^a   Bihari, Aurelia ^a   Mizuguchi, Shinjiro ^a   Yoshida, Norimasa ^c   Yoshikawa, Toshikazu ^c   Fraser, Douglas D ^a   Potter, Richard F ^a,b   Cepinskas, Gediminas ^a  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Adhesion molecules; Gut; Inflammation; Mice; Neutrophilic leukocytes

Indexed keywords

ANTIINFLAMMATORY AGENT; CARBON MONOXIDE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; TRICARBONYLDICHLORORUTHENIUM; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOACCUMULATION; C57BL 6 MOUSE; CONTROLLED STUDY; DRUG MECHANISM; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; INTESTINE ISCHEMIA; LEUKOCYTE ADHERENCE; LEUKOCYTE ROLLING; MALE; MICROCIRCULATION; MOUSE; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL COUNT; NONHUMAN; PROTEIN EXPRESSION; REPERFUSION INJURY; TISSUE LEVEL; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOTTING, WESTERN; CARBON DIOXIDE; E-SELECTIN; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL AGENTS; INFLAMMATION MEDIATORS; INFLAMMATORY BOWEL DISEASES; INTERCELLULAR ADHESION MOLECULE-1; JEJUNUM; LEUKOCYTE ROLLING; MALE; MESENTERIC VASCULAR OCCLUSION; MICE; MICE, INBRED C57BL; MICROSCOPY, VIDEO; NEUTROPHIL INFILTRATION; NF-KAPPA B; ORGANOMETALLIC COMPOUNDS; REPERFUSION INJURY; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 77952586011     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10753-009-9162-y     Document Type: Article

References (55)

1. U Haglund 1994 Gut ischaemia Gut 35 S73 S76 10.1136/gut.35.1-Suppl.S73 1:STN:280:DyaK2c7ntFWgtQ%3D%3D 8125397 (Pubitemid 24059513)
2. LA Hernandez MB Grisham B Twohig KE Arfors JM Harlan DN Granger 1987 Role of neutrophils in ischemia-reperfusion-induced microvascular injury Am J Physiol 253 H699 H703 1:STN:280:DyaL2szitlKgsA%3D%3D 3631303
3. DG Souza AT Vieira V Pinho LP Sousa AA Andrade CA Bonjardim, et al. 2005 NF-kappaB plays a major role during the systemic and local acute inflammatory response following intestinal reperfusion injury Br J Pharmacol 145 246 254 10.1038/sj.bjp.0706190 1:CAS:528:DC%2BD2MXkt1ShurY%3D 15765103 (Pubitemid 40756529)
4. L Zou B Attuwaybi BC Kone 2003 Effects of NF-kappa B inhibition on mesenteric ischemia-reperfusion injury Am J Physiol Gastrointest Liver Physiol 284 G713 G721 1:CAS:528:DC%2BD3sXjtlyrs7o%3D 12466147
5. G Cepinskas CW Lush PR Kvietys 1999 Anoxia/reoxygenation-induced tolerance with respect to polymorphonuclear leukocyte adhesion to cultured endothelial cells. A nuclear factor-kappaB-mediated phenomenon Circ Res 84 103 112 1:CAS:528:DyaK1MXmslGhsA%3D%3D 9915779 (Pubitemid 29074885)
6. P Kubes J Hunter DN Granger 1992 Ischemia/reperfusion-induced feline intestinal dysfunction: importance of granulocyte recruitment Gastroenterology 103 807 812 1:STN:280:DyaK38zmtlWmtg%3D%3D 1323498
7. J Panes M Perry DN Granger 1999 Leukocyte-endothelial cell adhesion: avenues for therapeutic intervention Br J Pharmacol 126 537 550 10.1038/sj.bjp.0702328 1:CAS:528:DyaK1MXhslWisb0%3D 10188959 (Pubitemid 29087827)
8. BL Colvin AW Thomson 2002 Chemokines, their receptors, and transplant outcome Transplantation 74 149 155 10.1097/00007890-200207270-00001 1:CAS:528:DC%2BD38XmsFagu7c%3D 12151723
9. MB Grisham LA Hernandez DN Granger 1986 Xanthine oxidase and neutrophil infiltration in intestinal ischemia Am J Physiol 251 G567 G574 1:CAS:528:DyaL28Xmt1ersbY%3D 3020994
10. F Amersi XD Shen D Anselmo J Melinek S Iyer DJ Southard, et al. 2002 Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathway Hepatology 35 815 823 10.1053/jhep.2002.32467 1:CAS:528:DC%2BD38XjtFSksrk%3D 11915027 (Pubitemid 34258375)
11. A Nakao K Kimizuka DB Stolz JS Neto T Kaizu AM Choi, et al. 2003 Carbon monoxide inhalation protects rat intestinal grafts from ischemia/reperfusion injury Am J Pathol 163 1587 1598 1:CAS:528:DC%2BD3sXotlegtLw%3D 14507665 (Pubitemid 37175105)
12. A Nakao AM Choi N Murase 2006 Protective effect of carbon monoxide in transplantation J Cell Mol Med 10 650 671 10.1111/j.1582-4934.2006.tb00426.x 1:CAS:528:DC%2BD2sXlvFClsLg%3D 16989726 (Pubitemid 44874275)
13. Mann BE, Motterlini R. 2007. CO and NO in medicine. Chem Commun (Camb) 4197-208. (Pubitemid 47598742)
14. MC Ott JR Scott A Bihari A Badhwar LE Otterbein DK Gray, et al. 2005 Inhalation of carbon monoxide prevents liver injury and inflammation following hind limb ischemia/reperfusion Faseb J 19 106 108 1:CAS:528: DC%2BD2MXitVGjuw%3D%3D 15514102 (Pubitemid 40069933)
15. T Kaizu A Ikeda A Nakao A Tsung H Toyokawa S Ueki, et al. 2008 Protection of transplant-induced hepatic ischemia/reperfusion injury with carbon monoxide via MEK/ERK1/2 pathway downregulation Am J Physiol Gastrointest Liver Physiol 294 G236 G244 10.1152/ajpgi.00144.2007 1:CAS:528:DC%2BD1cXhtVWrt7w%3D 18006605
16. J Kohmoto A Nakao DB Stolz T Kaizu A Tsung A Ikeda, et al. 2007 Carbon monoxide protects rat lung transplants from ischemia-reperfusion injury via a mechanism involving p38 MAPK pathway Am J Transplant 7 2279 2290 10.1111/j.1600-6143.2007.01940.x 1:CAS:528:DC%2BD2sXhtFyjs73I 17711551 (Pubitemid 47347863)
17. FB Mayr A Spiel J Leitner C Marsik P Germann R Ullrich, et al. 2005 Effects of carbon monoxide inhalation during experimental endotoxemia in humans Am J Respir Crit Care Med 171 354 360 10.1164/rccm.200404-446OC 15557136 (Pubitemid 40223403)
18. Y Guo AB Stein WJ Wu W Tan X Zhu QH Li, et al. 2004 Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo Am J Physiol Heart Circ Physiol 286 H1649 H1653 10.1152/ajpheart.00971.2003 1:CAS:528:DC%2BD2cXkt1ensb4%3D 14704226 (Pubitemid 38525450)
19. R Motterlini JE Clark R Foresti P Sarathchandra BE Mann CJ Green 2002 Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities Circ Res 90 E17 E24 10.1161/hh0202.104530 1:CAS:528:DC%2BD38Xhtl2ltro%3D 11834719
20. R Motterlini BE Mann TR Johnson JE Clark R Foresti CJ Green 2003 Bioactivity and pharmacological actions of carbon monoxide-releasing molecules Curr Pharm Des 9 2525 2539 10.2174/1381612033453785 1:CAS:528: DC%2BD3sXotlWjtrs%3D 14529551 (Pubitemid 37236371)
21. R Foresti J Hammad JE Clark TR Johnson BE Mann A Friebe, et al. 2004 Vasoactive properties of CORM-3, a novel water-soluble carbon monoxide-releasing molecule Br J Pharmacol 142 453 460 10.1038/sj.bjp.0705825 1:CAS:528: DC%2BD2cXltlejtbg%3D 15148243 (Pubitemid 38869858)
22. JE Clark P Naughton S Shurey CJ Green TR Johnson BE Mann, et al. 2003 Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule Circ Res 93 e2 e8 10.1161/01.RES.0000084381.86567.08 1:CAS:528: DC%2BD3sXlsVOntrg%3D 12842916
23. G Cepinskas K Katada A Bihari RF Potter 2008 Carbon monoxide liberated from carbon monoxide-releasing molecule CORM-2 attenuates inflammation in the liver of septic mice Am J Physiol Gastrointest Liver Physiol 294 G184 G191 10.1152/ajpgi.00348.2007 1:CAS:528:DC%2BD1cXhtVWrtrg%3D 17991708
24. BW Sun Q Jin Y Sun ZW Sun X Chen ZY Chen, et al. 2007 Carbon liberated from CO-releasing molecules attenuates leukocyte infiltration in the small intestine of thermally injured mice World J Gastroenterol 13 6183 6190 10.3748/wjg.13.6183 1:CAS:528:DC%2BD1cXhtVOhtbo%3D 18069757
25. P Sawle R Foresti BE Mann TR Johnson CJ Green R Motterlini 2005 Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages Br J Pharmacol 145 800 810 10.1038/sj.bjp.0706241 1:CAS:528:DC%2BD2MXmt1Wms74%3D 15880142 (Pubitemid 41076287)
26. P Urquhart G Rosignoli D Cooper R Motterlini M Perretti 2007 Carbon monoxide-releasing molecules modulate leukocyte-endothelial interactions under flow J Pharmacol Exp Ther 321 656 662 10.1124/jpet.106.117218 1:CAS:528:DC%2BD2sXltFehurs%3D 17289832 (Pubitemid 46624509)
27. K Katada A Bihari A Badhwar N Yoshida T Yoshikawa RF Potter, et al. 2009 Hindlimb ischemia/reperfusion-induced remote injury to the small intestine: role of inducible nitric-oxide synthase-derived nitric oxide J Pharmacol Exp Ther 329 919 927 10.1124/jpet.108.148460 1:CAS:528:DC%2BD1MXms1ehurw%3D 19270191
28. CW Lush G Cepinskas PR Kvietys 2003 Regulation of intestinal nuclear factor-kappaB activity and E-selectin expression during sepsis: a role for peroxynitrite Gastroenterology 124 118 128 10.1053/gast.2003.50001 1:CAS:528:DC%2BD3sXot1anug%3D%3D 12512036 (Pubitemid 36055345)
29. G Cepinskas J Savickiene CV Ionescu PR Kvietys 2003 PMN transendothelial migration decreases nuclear NFkappaB in IL-1beta-activated endothelial cells: role of PECAM-1 J Cell Biol 161 641 651 10.1083/jcb.200212048 1:CAS:528:DC%2BD3sXjvVeqsb4%3D 12743110 (Pubitemid 36578586)
30. SF Liu AB Malik 2006 NF-kappa B activation as a pathological mechanism of septic shock and inflammation Am J Physiol Lung Cell Mol Physiol 290 L622 L645 10.1152/ajplung.00477.2005 1:CAS:528:DC%2BD28Xks1Slur8%3D 16531564 (Pubitemid 43738989)
31. YM Janssen-Heininger ME Poynter PA Baeuerle 2000 Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB Free Radic Biol Med 28 1317 1327 10.1016/S0891-5849(00)00218-5 1:CAS:528: DC%2BD3cXltlWgtLg%3D 10924851 (Pubitemid 30621476)
32. M Zabalgoitia JT Colston SV Reddy JW Holt RF Regan DE Stec, et al. 2008 Carbon monoxide donors or heme oxygenase-1 (HO-1) overexpression blocks interleukin-18-mediated NF-kappaB-PTEN-dependent human cardiac endothelial cell death Free Radic Biol Med 44 284 298 10.1016/j.freeradbiomed.2007.08.012 1:CAS:528:DC%2BD1cXpt1KlsQ%3D%3D 18215737
33. T Fujita K Toda A Karimova SF Yan Y Naka SF Yet, et al. 2001 Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis Nat Med 7 598 604 10.1038/87929 1:CAS:528:DC%2BD3MXjsVaku7w%3D 11329062 (Pubitemid 32448328)
34. R Motterlini 2007 Carbon monoxide-releasing molecules (CO-RMs): vasodilatory, anti-ischaemic and anti-inflammatory activities Biochem Soc Trans 35 1142 1146 10.1042/BST0351142 1:CAS:528:DC%2BD2sXht1eru7vM 17956297 (Pubitemid 350214248)
35. R Motterlini P Sawle J Hammad S Bains R Alberto R Foresti, et al. 2005 CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule Faseb J 19 284 286 1:CAS:528:DC%2BD2MXhtFehsLw%3D 15556971 (Pubitemid 40189283)
36. O De Backer E Elinck B Blanckaert L Leybaert R Motterlini RA Lefebvre 2009 Water-soluble CO-releasing molecules reduce the development of postoperative ileus via modulation of MAPK/HO-1 signalling and reduction of oxidative stress Gut 58 347 356 10.1136/gut.2008.155481 19022916
37. A Sandouka BJ Fuller BE Mann CJ Green R Foresti R Motterlini 2006 Treatment with CO-RMs during cold storage improves renal function at reperfusion Kidney Int 69 239 247 10.1038/sj.ki.5000016 1:CAS:528:DC%2BD28XksVKrsA%3D%3D 16408112 (Pubitemid 43323073)
38. SW Chung X Liu AA Macias RM Baron MA Perrella 2008 Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice J Clin Invest 118 239 247 10.1172/JCI32730 1:CAS:528:DC%2BD1cXksFOksg%3D%3D 18060048
39. K Srisook SS Han HS Choi MH Li H Ueda C Kim, et al. 2006 CO from enhanced HO activity or from CORM-2 inhibits both O2- and NO production and downregulates HO-1 expression in LPS-stimulated macrophages Biochem Pharmacol 71 307 318 10.1016/j.bcp.2005.10.042 1:CAS:528:DC%2BD2MXhtlCqurzN 16329999 (Pubitemid 41817291)
40. S Mizuguchi J Stephen R Bihari N Markovic S Suehiro A Capretta, et al. 2009 CORM-3-derived CO modulates polymorphonuclear leukocyte migration across the vascular endothelium by reducing levels of cell surface-bound elastase Am J Physiol Heart Circ Physiol 297 H920 H929 10.1152/ajpheart.00305.2009 1:CAS:528:DC%2BD1MXhtFGrtbzN 19561312
41. D Morse SE Pischke Z Zhou RJ Davis RA Flavell T Loop, et al. 2003 Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1 J Biol Chem 278 36993 36998 10.1074/jbc.M302942200 1:CAS:528:DC%2BD3sXnsV2mtLw%3D 12857751 (Pubitemid 37175212)
42. G Cepinskas JX Wilson 2008 Inflammatory response in microvascular endothelium in sepsis: role of oxidants J Clin Biochem Nutr 42 175 184 10.3164/jcbn.2008026 1:CAS:528:DC%2BD1cXotFaisr8%3D 18545638 (Pubitemid 351916671)
43. K Ley C Laudanna MI Cybulsky S Nourshargh 2007 Getting to the site of inflammation: the leukocyte adhesion cascade updated Nat Rev Immunol 7 678 689 10.1038/nri2156 1:CAS:528:DC%2BD2sXpsV2qtb0%3D 17717539 (Pubitemid 47327397)
44. S Massberg K Messmer 1998 The nature of ischemia/reperfusion injury Transplant Proc 30 4217 4223 10.1016/S0041-1345(98)01397-9 1:STN:280: DyaK1M%2Fot1yluw%3D%3D 9865350 (Pubitemid 29013209)
45. Ley K, Reutershan J. 2006. Leucocyte-endothelial interactions in health and disease. Handb Exp Pharmacol 97-133.
46. P Kubes 1999 The role of adhesion molecules and nitric oxide in intestinal and hepatic ischemia/reperfusion Hepatogastroenterology. 46 Suppl 2 1458 1463 1:CAS:528:DyaK1MXltVWgs7g%3D 10431707 (Pubitemid 29313185)
47. J Russell CJ Epstein MB Grisham JS Alexander KY Yeh DN Granger 2000 Regulation of E-selectin expression in postischemic intestinal microvasculature Am J Physiol Gastrointest Liver Physiol 278 G878 G885 1:CAS:528: DC%2BD3cXks1Knur4%3D 10859217
48. A Freitas JC Alves-Filho DD Secco AF Neto SH Ferreira C Barja-Fidalgo, et al. 2006 Heme oxygenase/carbon monoxide-biliverdin pathway down regulates neutrophil rolling, adhesion and migration in acute inflammation Br J Pharmacol 149 345 354 10.1038/sj.bjp.0706882 1:CAS:528:DC%2BD28XhtVOmu7fP 16953189 (Pubitemid 44582241)
49. AS Baldwin Jr 1996 The NF-kappa B and I kappa B proteins: new discoveries and insights Annu Rev Immunol 14 649 683 10.1146/annurev.immunol.14.1.649 1:CAS:528:DyaK28XitlCgtbc%3D 8717528 (Pubitemid 26130197)
50. G Bonizzi J Piette MP Merville V Bours 2000 Cell type-specific role for reactive oxygen species in nuclear factor-kappaB activation by interleukin-1 Biochem Pharmacol 59 7 11 10.1016/S0006-2952(99)00290-7 1:CAS:528: DC%2BD3cXhtV2hsg%3D%3D 10605929
51. CK Chang MV Albarillo W Schumer 2001 Therapeutic effect of dimethyl sulfoxide on ICAM-1 gene expression and activation of NF-kappaB and AP-1 in septic rats J Surg Res 95 181 187 10.1006/jsre.2000.6033 1:CAS:528: DC%2BD3MXls1Wrsg%3D%3D 11162043 (Pubitemid 34953553)
52. TS Blackwell FE Yull CL Chen A Venkatakrishnan TR Blackwell DJ Hicks, et al. 2000 Multiorgan nuclear factor kappa B activation in a transgenic mouse model of systemic inflammation Am J Respir Crit Care Med 162 1095 1101 1:STN:280:DC%2BD3cvotFaitg%3D%3D 10988136
53. PJ Barnes M Karin 1997 Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases N Engl J Med 336 1066 1071 10.1056/NEJM199704103361506 1:CAS:528:DyaK2sXis1SrsLw%3D 9091804 (Pubitemid 27163860)
54. T Kaizu A Nakao A Tsung H Toyokawa R Sahai DA Geller, et al. 2005 Carbon monoxide inhalation ameliorates cold ischemia/reperfusion injury after rat liver transplantation Surgery 138 229 235 10.1016/j.surg.2005.06.015 16153431 (Pubitemid 41253805)
55. J Megias J Busserolles MJ Alcaraz 2007 The carbon monoxide-releasing molecule CORM-2 inhibits the inflammatory response induced by cytokines in Caco-2 cells Br J Pharmacol 150 977 986 10.1038/sj.bjp.0707184 1:CAS:528:DC%2BD2sXkt1Chs7g%3D 17339836 (Pubitemid 46625094)